Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Mixed Tumor, Mullerian

ClinicalTrials.gov lists 1 trial for Mixed Tumor, Mullerian or a narrower condition beneath it.

MeSH D018200 Neoplasms Neoplasm C04
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 1 Publications Publications 8 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 1 Publications Publications 8

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Mixed Tumor, Mullerian itself; the rest are tagged with a narrower condition beneath it.

Get the Mixed Tumor, Mullerian report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Mixed Tumor, Mullerian trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2001 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Mixed Tumor, Mullerian trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 2 1

How many Mixed Tumor, Mullerian trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which serious adverse events do Mixed Tumor, Mullerian trials report? (1)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Neutropenia 9 1

Which publications cover Mixed Tumor, Mullerian? (8)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer. Gynecologic oncology 2013 Yes
Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors. Gynecologic oncology 2010 Yes
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Gynecologic oncology 2009 Yes
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecologic oncology 2006 Yes
Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecologic oncology 2005 Yes

Showing 5 of 8 publications.

Start your 14-day trial Email me all 8 publications as a PDF

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages